Publications

Found 8 results
Author Title Type [ Year(Asc)]
Filters: Author is Clegg, Dennis O and First Letter Of Title is S  [Clear All Filters]
2022
Kashani AH, Lebkowski JS, Hinton DR, Zhu D, Faynus MA, Chen S, Rahhal FM, Avery RL, Salehi-Had H, Chan C et al..  2022.  Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.. Stem Cell Reports. 17(3):448-458.
2020
Kashani AH, Uang J, Mert M, Rahhal F, Chan C, Avery RL, Dugel P, Chen S, Lebkowski J, Clegg DO et al..  2020.  Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.. Ophthalmol Retina. 4(3):264-273.
2016
Clevenger TN, Luna G, Fisher SK, Clegg DO.  2016.  Strategies for bioengineered scaffolds that support adipose stem cells in regenerative therapies. Regenerative Medicine.
Koss MJ, Falabella P, Stefanini FR, Pfister M, Thomas BB, Kashani AH, Brant R, Zhu D, Clegg DO, Hinton DR et al..  2016.  Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs. Graefes Arch Clin Exp Ophthalmol. 254(8):1553-65.
Thomas BB, Zhu D, Zhang L, Thomas PB, Hu Y, Nazari H, Stefanini F, Falabella P, Clegg DO, Hinton DR et al..  2016.  Survival and Functionality of hESC-Derived Retinal Pigment Epithelium Cells Cultured as a Monolayer on Polymer Substrates Transplanted in RCS Rats. Invest Ophthalmol Vis Sci. 57(6):2877-87.
2015
Nazari H, Zhang L, Zhu D, Chader GJ, Falabella P, Stefanini F, Rowland T, Clegg DO, Kashani AH, Hinton DR et al..  2015.  Stem cell based therapies for age-related macular degeneration: The promises and the challenges. Progress in Retinal & Eye Research. 48:1-39.
2010
Kolhar P, Kotamraju VRamana, Hikita ST, Clegg DO, Ruoslahti E.  2010.  Synthetic surfaces for human embryonic stem cell culture. Journal of Biotechnology. 146(3):143-6.
2008
Buchholz DE, Hikita ST, Radeke MJ, Blashke KE, Johnson LV, Clegg DO.  2008.  Stem cell derived retinal pigment Epithelium for the treatment of age-related Macular degeneration. Journal of Vision. 8:47–47.